Crescita Therpeutc (TSE:CTX) has released an update.
Crescita Therapeutics Inc., a Canadian dermatology company, has been chosen as the exclusive manufacturing partner in a five-year agreement with a major healthcare services provider to supply skin sanitation products for public healthcare organizations. The deal could potentially generate annual revenue of up to $6 million by the end of the term, with future revenue opportunities through competitive bidding processes and potential expansions in collaborations.
For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.
